Accordingly, treatment with Ly294002, a pan PI3K inhibitor, limits the severity of sepsis by reducing CD40L-mediated endothelial cell damage and, therefore, suppressing the extravasation of inflammatory cells in the lung parenchyma [10]. This evidence concerns the gene PIK3CD and Sepsis.